Market Place
Sourcing Support
MacroGenics Enters Agreement With TerSera For MARGENZA®
22 Oct 2024 //
BUSINESSWIRE
Zai Lab eyes imminent China filing for MacroGenics` HER2 drug
06 Oct 2021 //
ENDPTS
MacroGenics flips over an OS dud for Margenza in turnaround from earlier data
08 Sep 2021 //
ENDPTS
MacroGenics Announces Lancet Oncology Publication of Margetuximab Data
10 Jul 2020 //
GLOBENEWSWIRE
MacroGenics Announces Margetuximab Granted Orphan Drug Designation in the U.S.
05 Jun 2020 //
PRESS RELEASE
MacroGenics Provides Update on FDA Review of Margetuximab for HER2-Positive MBC
28 May 2020 //
GLOBENEWSWIRE
MacroGenics Announces Submission of Margetuximab Biologics License Application
19 Dec 2019 //
PRESS RELEASE
MacroGenics` margetuximab nets OS gain in advanced breast cancer
11 Dec 2019 //
FIERCE BIOTECH
Macrogenics` margetuximab shows survival benefit in late-stage breast cancer
23 Oct 2019 //
SEEKINGALPHA
Macrogenics` margetuximab shows survival benefit in late-stage breast study
22 Oct 2019 //
SEEKINGALPHA
MacroGenics reports positive results from phase 3 Sophia study of margetuximab
08 Feb 2019 //
PHARMA BIZ
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.